AI device aims to read your back pain without you saying a word

NCT ID NCT07244237

Completed Knowledge-focused Sponsor: Amasya University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an artificial intelligence-assisted electrical stimulation device (StimaWELL 120MTRS) can measure chronic back pain as accurately as patients' own ratings. 78 adults with back pain for over three months had their pain measured by the device, a pressure-based dolorimeter, and a standard 0-10 pain scale. The goal was to see if the device's readings match what patients report, potentially offering a more objective pain assessment tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a more objective way to measure back pain, helping doctors assess pain without relying solely on what patients say.
What could go wrong: This is a small, completed observational study, not a treatment trial. The device may not prove more accurate than simple pain scales, and results may not apply to all back pain patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC BACK PAIN

Contacts and locations

Locations

AMASYAŞAM Sağlıklı Yaşam Merkezi

Amasya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.